New Transcription Factors and Their Role in Diabetes and Therapy

New Transcription Factors and Their Role in Diabetes and Therapy, 1st Edition

Advances in Molecular and Cellular Endocrinology

New Transcription Factors and Their Role in Diabetes and Therapy, 1st Edition,Jacob Friedman,ISBN9780444511584

J Friedman   

Elsevier Science




240 X 165

An excellent resource for the latest endocrine research

Print Book + eBook

USD 211.80
USD 353.00

Buy both together and save 40%

Print Book


In Stock

Estimated Delivery Time
USD 178.00

eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : PDF

USD 175.00
Add to Cart

Key Features

*Applies molecular biology to transcriptional regulation of metabolism and obesity
*Underscores the clinical relevance of transcription factors
*Provides a valuable overview of the current status of the field


This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mechanisms of diabetes and obesity.

Volume 5 provides an overview of the status of the field, while also providing valuable information of practical utility to those who do not necessarily work in this field. The integration of basic biology with physiologically and clinically relevant proteins should provide the reader with a theoretical background to understanding the strategies for new potential therapeutic targets and their application to disease.


Endocrinologists, Biomedical researchers, Geneticists, Molecular and Cellular Biologists

Jacob Friedman

Affiliations and Expertise

University of Colorado Health Sciences Center, Denver, CO, USA

New Transcription Factors and Their Role in Diabetes and Therapy, 1st Edition

1. PPARs as therapeutic targets for treating diabetes and insulin resistance
2. Genetic regulators of human obesity and diabetes
3. NF-kb, insulin resistance and the actions of salicylates
4. Wnt signaling and C/EBPs role in adipogenesis
5. Regulation of hepatic gluconeogenesis C/EPBs
6. Forkhead proteins and regulation of hepatic gene expression
7. Control of mitochondrial biogenesis through PGC-1
8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications
9. FOXC2 controls resistance to obesity and Type II diabetes
10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
11. GATA proteins as molecular gatekeeprs of the adipocyte
12. Diabetes regulation of gene expression by CREB
13. Molecular etiologies of MODY and other early-onset forms of diabetes
14. Liver X receptors as potential drug targets for Diabetes and its disorders
15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis
16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys
17. PPARgamma and metabolism: Insights from the study of human genetic variants

Cyber Week Pre-Sale | Use Code CYBOOK15

Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy

Contact Us